SCHEMBL1348239

SCHEMBL1348239

O=C(Cl)Oc1ccc(-c2cccnc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 6/20 0.56
MKNK2 Q9HBH9 6/20 0.56
CYP19A1 P11511 3/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2A6 P11509 2/20 0.50
ALDH1A1 P00352 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
PORCN Q9H237 1/20 0.50
NPC1 O15118 2/20 0.49
TP53 P04637 2/20 0.49
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
PKM P14618 1/20 0.49
CYP11B1 P15538 2/20 0.47
CYP11B2 P19099 2/20 0.47
CYP17A1 P05093 1/20 0.46
CA12 O43570 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1348104 0.84 KMO (0.54) MKNK1MKNK2CYP19A1CYP3A4CYP2A6
SCHEMBL27615591 0.83 MKNK1 (0.63) MKNK1MKNK2CYP19A1CYP3A4CYP2A6
SCHEMBL2216123 0.83 NPC1 (0.67) MKNK1MKNK2CYP19A1CYP3A4CYP2A6
SCHEMBL1532656 0.80 KMT2A (0.58) ALDH1A1CYP1A2CYP2C9CYP2C19KMT2A
SCHEMBL1347723 0.80 KMT2A (0.53) CYP1A2CYP2C9CYP2C19NPC1RAB9A
SCHEMBL6565732 0.80 HSD17B10 (0.47) ALDH1A1CYP1A2CYP2C9CYP2C19NPC1
Hydrochloric Acid SCHEMBL10604528 0.79 KMT2A (0.61) ALDH1A1CYP1A2CYP2C9CYP2C19KMT2A
SCHEMBL206263 0.77 MKNK1 (0.71) MKNK1MKNK2CYP19A1CYP3A4CYP2A6
Benzene SCHEMBL28562974 0.75 MKNK1 (0.50) MKNK1MKNK2CYP19A1CYP3A4CYP2A6
SCHEMBL24534338 0.75 CYP2A6 (0.88) MKNK1MKNK2CYP19A1CYP3A4CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063021-B2 Ketolide anti-infective compounds KOSAN BIOSCIENCES INCORPORATED (US) 2011-11-22 US disclosed
US-20050272672-A1 Ketolide anti-infective compounds KOSAN BIOSCIENCES, INC. (US) 2005-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272672-A1 Ketolide anti-infective compounds HK1, AKR1D1, KHK MKNK1 1526/4885MKNK2 2441/4885CYP19A1 1812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.